Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 7.79
(1.7%)
CNY 7.79
(1.7%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 290.82 Million CNY | 12.85% |
| 2022 | 257.71 Million CNY | 60.92% |
| 2021 | 160.15 Million CNY | 65.77% |
| 2020 | 96.61 Million CNY | 58.1% |
| 2019 | 61.1 Million CNY | 29.35% |
| 2018 | 47.24 Million CNY | -21.64% |
| 2017 | 60.28 Million CNY | -3.72% |
| 2016 | 62.61 Million CNY | -4.1% |
| 2015 | 65.29 Million CNY | 144.34% |
| 2014 | 26.72 Million CNY | 44.07% |
| 2013 | 18.54 Million CNY | 556.0% |
| 2012 | 2.82 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 64.95 Million CNY | -45.94% |
| 2024 Q1 | 120.15 Million CNY | 243.66% |
| 2024 Q3 | 52.33 Million CNY | -19.43% |
| 2023 Q2 | 74.65 Million CNY | -31.51% |
| 2023 Q3 | 72.2 Million CNY | -3.28% |
| 2023 FY | 290.82 Million CNY | 12.85% |
| 2023 Q1 | 109 Million CNY | 100.49% |
| 2023 Q4 | 34.96 Million CNY | -51.58% |
| 2022 Q4 | 54.36 Million CNY | -12.24% |
| 2022 Q2 | 60.27 Million CNY | -25.69% |
| 2022 Q1 | 81.11 Million CNY | 114.84% |
| 2022 FY | 257.71 Million CNY | 60.92% |
| 2022 Q3 | 61.94 Million CNY | 2.77% |
| 2021 Q2 | 43.39 Million CNY | -11.48% |
| 2021 FY | 160.15 Million CNY | 65.77% |
| 2021 Q1 | 49.01 Million CNY | 115.58% |
| 2021 Q4 | 37.75 Million CNY | 25.92% |
| 2021 Q3 | 29.98 Million CNY | -30.89% |
| 2020 Q3 | 16.09 Million CNY | -53.78% |
| 2020 Q2 | 34.82 Million CNY | 51.69% |
| 2020 FY | 96.61 Million CNY | 58.1% |
| 2020 Q1 | 22.95 Million CNY | 315.28% |
| 2020 Q4 | 22.73 Million CNY | 41.26% |
| 2019 Q3 | 20.43 Million CNY | -23.55% |
| 2019 Q2 | 26.72 Million CNY | 217.23% |
| 2019 Q1 | 8.42 Million CNY | -29.81% |
| 2019 FY | 61.1 Million CNY | 29.35% |
| 2019 Q4 | 5.52 Million CNY | -72.94% |
| 2018 Q1 | 2.41 Million CNY | -90.09% |
| 2018 Q3 | 8.26 Million CNY | -66.34% |
| 2018 Q2 | 24.55 Million CNY | 917.1% |
| 2018 FY | 47.24 Million CNY | -21.64% |
| 2018 Q4 | 12 Million CNY | 45.2% |
| 2017 FY | 60.28 Million CNY | -3.72% |
| 2017 Q3 | 7.81 Million CNY | -52.17% |
| 2017 Q2 | 16.34 Million CNY | 39.05% |
| 2017 Q1 | 11.75 Million CNY | -54.67% |
| 2017 Q4 | 24.37 Million CNY | 211.84% |
| 2016 Q1 | 13.22 Million CNY | 0.0% |
| 2016 Q3 | 14.33 Million CNY | 57.2% |
| 2016 Q2 | 9.12 Million CNY | -31.05% |
| 2016 Q4 | 25.92 Million CNY | 80.85% |
| 2016 FY | 62.61 Million CNY | -4.1% |
| 2015 FY | 65.29 Million CNY | 144.34% |
| 2015 Q1 | 11.43 Million CNY | 0.0% |
| 2014 FY | 26.72 Million CNY | 44.07% |
| 2013 FY | 18.54 Million CNY | 556.0% |
| 2012 FY | 2.82 Million CNY | 0.0% |